Cannabis
CannaOne Technologies Enters into an Agreement to Acquire 100% Ownership of Real Life Sciences Inc., and the BWell US CBD Marketplace
CannaOne Technologies Inc. (CSE: CNNA; OTC: CNONF; and Frankfurt: 3CT) (“CannaOne” or the “Company“), a leading cannabis e-commerce technology company, is pleased to announce that it has entered into a Letter of Intent (“LOI”) to acquire 100% interest in Real Life Sciences Inc. (“Real Life Sciences”).
On April 23rd, 2019, CannaOne Technologies announced a formal partnership with Real Life Sciences to launch and operate the BWell CBD online marketplace in the US. Under the terms of this agreement Real Life Sciences acted as local managing partners for the BWell online marketplace providing strategic management, financial and business development expertise. As the managing partner of the BWell Marketplace, Real Life Sciences maintained a 75.1% ownership interest.
CannaOne Technologies CEO, Mr. Riby-Williams, commented “Real Life Sciences’ expertise, vast network and strong relationships within the US has brought substantial value to the BWell marketplace during the past months and has been a key factor in the early launch for the business. BWell (www.thebwellmarket.com) is now capable of immediate sale and delivery of 140 high quality CBD products at extremely competitive prices to thousands of potential households in US. We believe that this infrastructure and knowledge contributed by Real Life Sciences to date provides substantial baseline support towards our Company now acquiring a sole ownership stake in the BWell marketplace that will assist to potentially provide long term substantial value to our shareholders.”
Under the terms of the LOI, following an extended period of Due Diligence, CannaOne Technologies has agreed to purchase Real Life Sciences for $2,000,000 CAD, such payment to be made in full through the issuance Company shares priced at a 20% discount to the market as at the date of Closing. The Closing Date for this transaction is set for October 25, 2019.
SOURCE CannaOne Technologies Inc.
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis6 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE1 week ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt6 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis6 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis4 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III